2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide
Número de CAS
879085-55-9
Fórmula Molecular
C19H14Cl2N2O3S
Peso Molecular
421.3
Pureza
98%
Indicación
Vismodegib Intermediate
Descripción del Producto

In January 2012, the US FDA approved vismodegib (also referred to as GDC-0449) for the treatment of adults with metastatic basal cell carcinoma (BCC),